Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
71 participants
INTERVENTIONAL
2007-05-31
2013-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Recurrent anal fistula
Patients with a complex anal fistula that recurred after surgery with an Anal Fistula Plug or and Endorectal Advancement Flap
Anal Fistula Plug
Surgical procedure for the treatment of anal fistula with an Anal Fistula Plug
Endorectal Advancement Flap
Surgical procedure for the treatment of anal fistula by an Advancement Mucosa Flap
No recurrence of anal fistula
Patients with a complex anal fistula that did not develop recurrence after surgery with an Anal Fistula Plug or and Endorectal Advancement Flap
Anal Fistula Plug
Surgical procedure for the treatment of anal fistula with an Anal Fistula Plug
Endorectal Advancement Flap
Surgical procedure for the treatment of anal fistula by an Advancement Mucosa Flap
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Anal Fistula Plug
Surgical procedure for the treatment of anal fistula with an Anal Fistula Plug
Endorectal Advancement Flap
Surgical procedure for the treatment of anal fistula by an Advancement Mucosa Flap
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Single anal fistula
* Surgically treated with anal fistula plug or endorectal advancement flap
Exclusion Criteria
* Pregnancy
* Patients treated with setons alone
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Oliver M Fisher, MD
Role: PRINCIPAL_INVESTIGATOR
University of Zurich
Antonio Nocito, MD
Role: STUDY_CHAIR
University of Zurich
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Zurich
Zurich, Canton of Zurich, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Adamina M, Hoch JS, Burnstein MJ. To plug or not to plug: a cost-effectiveness analysis for complex anal fistula. Surgery. 2010 Jan;147(1):72-8. doi: 10.1016/j.surg.2009.05.018. Epub 2009 Sep 6.
Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibanes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009 Aug;250(2):187-96. doi: 10.1097/SLA.0b013e3181b13ca2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KEK-ZH-Nr. 2013-XYZ
Identifier Type: OTHER
Identifier Source: secondary_id
AFPERAF
Identifier Type: -
Identifier Source: org_study_id